Article ; Online: Post-treatment with propofol inhibits inflammatory response in LPS-induced alveolar type II epithelial cells.
Experimental and therapeutic medicine
2022 Volume 23, Issue 4, Page(s) 249
Abstract: Over-inflammation and severe lung injury are major causes of morbidity and mortality in patients with coronavirus disease 2019 (COVID-19). With the COVID-19 pandemic, an increasing number of patients with preexisting lung injury and inflammation are ... ...
Abstract | Over-inflammation and severe lung injury are major causes of morbidity and mortality in patients with coronavirus disease 2019 (COVID-19). With the COVID-19 pandemic, an increasing number of patients with preexisting lung injury and inflammation are undergoing surgery or artificial ventilation under sedation in intensive care units, where 2,6-diisopropylphenol (propofol) is a commonly used drug for sedation. The aim of the present study was to investigate whether post-inflammation treatment with propofol protects epithelial type II cells against inflammation in an |
---|---|
Language | English |
Publishing date | 2022-01-31 |
Publishing country | Greece |
Document type | Journal Article |
ZDB-ID | 2683844-8 |
ISSN | 1792-1015 ; 1792-0981 |
ISSN (online) | 1792-1015 |
ISSN | 1792-0981 |
DOI | 10.3892/etm.2022.11174 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.